"Now that most older adults have at least one mobile device,...
Category:
Pandemic
Latest
Pandemic propels workers closer to four-day week
From Iceland to Australia, governments and business are testing...
WHO: Global COVID-19 case counts decline 17 per cent in latest week
"The prevalence of the omicron variant has increased globally and...
After COVID-19, ‘black fungus’ robs some in India of their eyesight
After a catastrophic second wave of COVID-19 in India since April which has seen its overall death toll climb to almost 400,000, thousands who contracted the virus also suffered from a rare fungal disease called mucormycosis, or “black fungus”.
EU plans new safety rules for the workplace wherever it is
In guidelines to protect almost 170 million EU workers over the 2021-2027 period, it will also seek to produce recommendations on mental health at work before the end of 2022.
Work-related accidents and illnesses cost the EU economy over 3.3% of gross domestic product per year, the Commission said. It said estimates showed that for every euro invested in occupational health and safety, the return for the employer is around twice as much as employees take less sick leave.
UK government set for leading role in insuring live entertainment
After months of closure or pared back performances with reduced audiences to allow social distancing, planning ahead to revive the sector is all but impossible without events cancellation insurance, theatre and music directors say. That makes government intervention crucial if the commercial sector will not pay.
SC directs NDMA to issue norms for financial help to kin of Covid victims
A special bench of Justices Ashok Bhushan and M R Shah said that the court cannot direct the Centre to fix a particular amount of financial help but the government can fix the minimum standard of amount to be paid as ex-gratia to family members of those who lost their lives due to COVID-19 while keeping various aspects in mind.
The top court asked the Centre to consider formulating an insurance scheme for cremation workers as proposed by the Finance Commission.
It also directs the authorities to issue appropriate guidelines for simplification of process of issuance of death certificates for Covid fatalities.
COVID-19 in children often asymptomatic, 2pc-3 pc infected kids may require hospitalisation: VK Paul
Dr Randeep Guleria, Director of All India Institute of Medical Sciences (AIIMS) New Delhi has said that there is no data, either from India or globally, to show that children will be seriously infected in subsequent waves.
India asks EU member states to consider Covishield, Covaxin vaccines under Green Pass scheme
India has requested the EU member nations to accept the vaccination certificate issued through the CoWIN portal.
The European Union”s Digital COVID certificate or “Green Pass” will be rolled out on Thursday with an aim to facilitate free movement during the COVID-19 pandemic is to come into effect on Thursday.
Highly transmissible Covid Delta variant detected in 96 countries, says WHO
Furthermore, a recent study conducted in Scotland and published in the international medical journal Lancet found that the hospitalization rate for patients infected with the Delta variant of COVID-19 was 85 per cent higher than for those infected with the Alpha variant.
“This particular Delta variant is faster, it is fitter, it will pick off the more vulnerable more efficiently than previous variants,” Michael Ryan, executive director of the WHO’s Health Emergencies Program, has commented recently.
Johnson & Johnson exploring ways to accelerate delivery of its COVID vaccine in India
‘We are in ongoing discussions with the Government of India and are exploring how best to accelerate our ability to deliver the Johnson & Johnson single dose COVID-19 vaccine to the people of India,” Johnson & Johnson India spokesperson said in a statement.
As per the recent announcement by the Drugs Controller General of India (DCGI), there is no longer a requirement to conduct bridging clinical studies of COVID-19 vaccines in India, the statement added.
Five Indian drugmakers to jointly start local trial of Merck & Co’s COVID-19 drug
Between March and April, each of these companies, including Sun Pharmaceutical Industries, Torrent Pharmaceuticals and privately held Emcure Pharmaceuticals, partnered with Merck to expand production of the drug, molnupiravir, hastening its availability in India to address a new wave of infections in the country.
Oxford study says mixing COVID-19 vaccines gives good protection
Professor Snape said these results are an invaluable guide to the use of mixed dose schedules, but the interval of four weeks studied here is shorter than the eight to 12-week schedule most commonly used for the Oxford-AstraZeneca vaccine.